Drug class
Selective calcium-entry blocker; piperazine derivative with H1-antihistamine activity
Mechanism of action
Reduces excessive transmembrane calcium entry and cellular calcium overload; it also has calmodulin-binding, histamine H1-blocking and sedative properties.
General use cases
- Prevention of migraine attacks
- Treatment of vertigo of central or peripheral origin in jurisdictions where authorised; use may be limited by depressive and extrapyramidal adverse effects
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
